March 17, 2017
12:30 PM Networking and Lunch
1:00 PM “From bench to bedside – and you thought molecule identification was difficult!”
Sean Lybrand, Director of Value, Access and Policy, Amgen Australia
2:00 – 4:00 Amgen Office Hours
Janis Naeve, Managing Director of Amgen Ventures and Samantha Palmer, Senior Licensing Manger, Amgen
To apply for Office Hours with Amgen, please contact Linda Eng.
Janis Naeve PhD joined Amgen in 2005 and is the Managing Director of Amgen Ventures, guiding the fund’s investment in biotechnology companies focused on discovering and developing human therapeutics. From 2002 to 2005, Dr. Naeve was director of Corporate Development at X-Ceptor Therapeutics, acquired by Exelixis.
Samantha Palmer PhD joined Amgen in 2015 and is the Senior Licensing Manager for Inflammation. She has an extensive background in immunology and microbiology and leads the Inflammation product search and evaluation efforts for Amgen business development covering Rheumatology, Dermatology, Respiratory and Specialty Gastro-Intestinal diseases.
